Prodromal psychosis detection in a counseling center population in China: An epidemiological and clinical study

Schizophrenia Research

Volumn 152, Issue 2-3, 2014, Pages 391-399

  Zhang, TianHong ^a   Li, HuiJun ^b,c   Woodberry, Kristen A ^c   Seidman, Larry J ^c   Zheng, LiNa ^d   Li, Hui ^a   Zhao, ShanShan ^a   Tang, YingYing ^a   Guo, Qian ^a   Lu, Xi ^a   Zhuo, KaiMing ^a   Qian, ZhenYing ^a   Chow, Annabelle ^e   Li, ChunBo ^a   Jiang, KaiDa ^a   Xiao, ZePing ^a   Wang, JiJun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FLORIDA A AND M UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d LIAOCHENG PEOPLE'S HOSPITAL   (China)

^e CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Clinical high risk; Early detection; Epidemiology; Help seeking; Ultra high risk

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHINA; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HELP SEEKING BEHAVIOR; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT COUNSELING; POSITIVE SYNDROME; PRIORITY JOURNAL; PRODROMAL QUESTIONNAIRE; PRODROMAL SYMPTOM; PSYCHOSIS; RISK ASSESSMENT; STRUCTURED INTERVIEW FOR PRODROMAL SYNDROMES; YOUNG ADULT;

CLINICAL HIGH RISK; EARLY DETECTION; EPIDEMIOLOGY; HELP-SEEKING; ULTRA-HIGH RISK;

ADOLESCENT; ADULT; AGE FACTORS; CHINA; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84892873547     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.11.039     Document Type: Article

References (65)

1. Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M., Walker E.F., Woods S.W., Heinssen R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr. Bull. 2007, 33(3):665-672.
2. Addington J., Epstein I., Reynolds A., Furimsky I., Rudy L., Mancini B., McMillan S., Kirsopp D., Zipursky R.B. Early detection of psychosis: finding those at clinical high risk. Early Interv. Psychiatry 2008, 2(3):147-153.
3. Addington J., Cornblatt B.A., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. Am. J. Psychiatry 2011, 168(8):800-805.
4. Allen P., Chaddock C.A., Howes O.D., Egerton A., Seal M.L., Fusar-Poli P., Valli I., Day F., McGuire P.K. Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis. Schizophr. Bull. 2012, 38(5):1040-1049.
5. Blanchard J.J., Horan W.P., Collins L.M. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?. Schizophr. Res. 2005, 77(2-3):151-165.
6. Borgwardt S.J., McGuire P.K., Aston J., Berger G., Dazzan P., Gschwandtner U., Pfluger M., D'Souza M., Radue E.W., Riecher-Rossler A. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br. J. Psychiatry Suppl. 2007, 51:s69-s75.
7. Bramon E., Shaikh M., Broome M., Lappin J., Berge D., Day F., Woolley J., Tabraham P., Madre M., Johns L., Howes O., Valmaggia L., Perez V., Sham P., Murray R.M., McGuire P. Abnormal P300 in people with high risk of developing psychosis. Neuroimage 2008, 41(2):553-560.
8. Brockhaus-Dumke A., Schultze-Lutter F., Mueller R., Tendolkar I., Bechdolf A., Pukrop R., Klosterkoetter J., Ruhrmann S. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol. Psychiatry 2008, 64(5):376-384.
9. Broome M.R., Woolley J.B., Johns L.C., Valmaggia L.R., Tabraham P., Gafoor R., Bramon E., McGuire P.K. Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur. Psychiatry 2005, 20(5-6):372-378.
10. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65(1):28-37.
11. Faraone S.V., Chen W.J., Goldstein J.M., Tsuang M.T. Gender differences in age at onset of schizophrenia. Br. J. Psychiatry 1994, 164(5):625-629.
12. Fusar-Poli P., Deste G., Smieskova R., Barlati S., Yung A.R., Howes O., Stieglitz R.D., Vita A., McGuire P., Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry 2012, 69(6):562-571.
13. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rossler A., Schultze-Lutter F., Keshavan M., Wood S., Ruhrmann S., Seidman L.J., Valmaggia L., Cannon T., Velthorst E., De Haan L., Cornblatt B., Bonoldi I., Birchwood M., McGlashan T., Carpenter W., McGorry P., Klosterkotter J., McGuire P., Yung A. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013, 70(1):107-120.
14. Fusar-Poli P., Byrne M., Badger S., Valmaggia L.R., McGuire P.K. Outreach and support in South London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur. Psychiatry 2013, 28(5):315-326.
15. Fusar-Poli P., Nelson B., Valmaggia L., Yung A.R., McGuire P.K. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr. Bull 2013, (in press). 10.1093/schbul/sbs136.
16. Giuliano A.J., Li H., Mesholam-Gately R.I., Sorenson S.M., Woodberry K.A., Seidman L.J. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr. Pharm. Des. 2012, 18(4):399-415.
17. Green C.E., McGuire P.K., Ashworth M., Valmaggia L.R. Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment. Psychol. Med. 2011, 41(2):243-250.
18. Hafner H., Maurer K., Loffler W., Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry 1993, 162:80-86.
19. Hsiao M.C., Liu C.Y., Yang Y.Y., Yeh E.K. Delusional disorder: retrospective analysis of 86 Chinese outpatients. Psychiatry Clin. Neurosci. 1999, 53(6):673-676.
20. Kelleher I., Murtagh A., Molloy C., Roddy S., Clarke M.C., Harley M., Cannon M. Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr. Bull. 2012, 38(2):239-246.
21. Klosterkotter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry 2001, 58(2):158-164.
22. Klosterkotter J., Schultze-Lutter F., Bechdolf A., Ruhrmann S. Prediction and prevention of schizophrenia: what has been achieved and where to go next?. World Psychiatry 2011, 10(3):165-174.
23. Koutsouleris N., Davatzikos C., Bottlender R., Patschurek-Kliche K., Scheuerecker J., Decker P., Gaser C., Moller H.J., Meisenzahl E.M. Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr. Bull. 2012, 38(6):1200-1215.
24. Lam M.M., Hung S.F., Chen E.Y. Transition to psychosis: 6-month follow-up of a Chinese high-risk group in Hong Kong. Aust. N. Z. J. Psychiatry 2006, 40(5):414-420.
25. Li X., Zhang X., Wang Q. The research on misunderstanding to consultation and referral of counseling psychologist. China J. Health Psychol. 2009, 19(2):245-247.
26. Loewy R.L., Bearden C.E., Johnson J.K., Raine A., Cannon T.D. The Prodromal Questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr. Res. 2005, 79(1):117-125.
27. Loewy R.L., Pearson R., Vinogradov S., Bearden C.E., Cannon T.D. Psychosis risk screening with the Prodromal Questionnaire-Brief version (PQ-B). Schizophr. Res. 2011, 129(1):42-46.
28. Mason O., Startup M., Halpin S., Schall U., Conrad A., Carr V. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophr. Res. 2004, 71(2-3):227-237.
29. McGlashan T.H., Addington J., Cannon T., Heinimaa M., McGorry P., O'Brien M., Penn D., Perkins D., Salokangas R.K., Walsh B., Woods S.W., Yung A. Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophr. Bull. 2007, 33(3):715-726.
30. Miller T.J., McGlashan T.H., Woods S.W., Stein K., Driesen N., Corcoran C.M., Hoffman R., Davidson L. Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 1999, 70(4):273-287.
31. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., Woods S.W. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry 2002, 159(5):863-865.
32. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the Structured Interview for Prodromal Syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29(4):703-715.
33. Miller T.J., Zipursky R.B., Perkins D., Addington J., Woods S.W., Hawkins K.A., Hoffman R., Preda A., Epstein I., Addington D., Lindborg S., Marquez E., Tohen M., Breier A., McGlashan T.H. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr. Res. 2003, 61(1):19-30.
34. Morrison A.P., French P., Walford L., Lewis S.W., Kilcommons A., Green J., Parker S., Bentall R.P. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br. J. Psychiatry 2004, 185:291-297.
35. Morrison A.P., French P., Parker S., Roberts M., Stevens H., Bentall R.P., Lewis S.W. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr. Bull. 2007, 33(3):682-687.
36. Morrison A.P., Stewart S.L., French P., Bentall R.P., Birchwood M., Byrne R., Davies L.M., Fowler D., Gumley A.I., Jones P.B., Lewis S.W., Murray G.K., Patterson P., Dunn G. Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Interv. Psychiatry 2011, 5(1):24-32.
37. Myles-Worsley M., Weaver S., Blailes F. Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis. Early Interv. Psychiatry 2007, 1(21):183-190.
38. Oyserman D., Lee S.W. Does culture influence what and how we think? Effects of priming individualism and collectivism. Psychol. Bull. 2008, 134(2):311-342.
39. Phillips L.J., Leicester S.B., O'Dwyer L.E., Francey S.M., Koutsogiannis J., Abdel-Baki A., Kelly D., Jones S., Vay C., Yung A.R., McGorry P.D. The PACE clinic: identification and management of young people at "ultra" high risk of psychosis. J. Psychiatr. Pract. 2002, 8(5):255-269.
40. Phillips L.J., McGorry P.D., Yuen H.P., Ward J., Donovan K., Kelly D., Francey S.M., Yung A.R. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr. Res. 2007, 96(1-3):25-33.
41. Piskulic D., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., McGlashan T.H. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012, 196(2-3):220-224.
42. Preti A., Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 2010, 123(1):30-36.
43. Raballo A., Laroi F. Psychosis risk syndrome and DSM-5: time for a dimensional approach to at-risk mental states?. Clin. Schizophr. Relat. Psychoses 2011, 5(3):155-158.
44. Rietdijk J., Klaassen R., Ising H., Dragt S., Nieman D.H., van de Kamp J., Cuijpers P., Linszen D., van der Gaag M. Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies. Acta Psychiatr. Scand. 2012, 126(1):21-30.
45. Ruhrmann S., Schultze-Lutter F., Maier W., Klosterkotter J. Pharmacological intervention in the initial prodromal phase of psychosis. Eur. Psychiatry 2005, 20(1):1-6.
46. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linszen D., Dingemans P., Birchwood M., Patterson P., Juckel G., Heinz A., Morrison A., Lewis S., von Reventlow H.G., Klosterkotter J. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch. Gen. Psychiatry 2009, 67(3):241-251.
47. Salokangas R.K., Ruhrmann S., von Reventlow H.G., Heinimaa M., Svirskis T., From T., Luutonen S., Juckel G., Linszen D., Dingemans P., Birchwood M., Patterson P., Schultze-Lutter F., Klosterkotter J. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophr. Res. 2012, 138(2-3):192-197.
48. Schultze-Lutter F., Ruhrmann S., Berning J., Maier W., Klosterkotter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr. Bull. 2010, 36(1):182-191.
49. Seidman L.J., Giuliano A.J., Meyer E.C., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Christensen B.K., Hawkins K., Heaton R., Keefe R.S., Heinssen R., Cornblatt B.A. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch. Gen. Psychiatry 2010, 67(6):578-588.
50. Simon A.E., Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr. Res. 2010, 116(2-3):168-172.
51. Simon A.E., Dvorsky D.N., Boesch J., Roth B., Isler E., Schueler P., Petralli C., Umbricht D. Defining subjects at risk for psychosis: a comparison of two approaches. Schizophr. Res. 2006, 81(1):83-90.
52. van Rijn S., Aleman A., de Sonneville L., Sprong M., Ziermans T., Schothorst P., van Engeland H., Swaab H. Neuroendocrine markers of high risk for psychosis: salivary testosterone in adolescent boys with prodromal symptoms. Psychol. Med. 2011, 41(9):1815-1822.
53. Woods S.W., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., McGlashan T.H. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr. Bull. 2009, 35(5):894-908.
54. Yang Y.P., Shen D.Y., Wang J.Y., Yang J. The reliability and validity of PDQ-4+ in China. Chin. J. Clin. Psychol. 2002, 10:165-168.
55. Yung A.R., McGorry P.D., McFarlane C.A., Jackson H.J., Patton G.C., Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 1996, 22(2):283-303.
56. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., Patton G.C., Jackson H.J. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br. J. Psychiatry Suppl. 1998, 172(33):14-20.
57. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67(2-3):131-142.
58. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C., Godfrey K., Buckby J. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust. N. Z. J. Psychiatry 2005, 39(11-12):964-971.
59. Yung A.R., Stanford C., Cosgrave E., Killackey E., Phillips L., Nelson B., McGorry P.D. Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr. Res. 2006, 84(1):57-66.
60. Yung A.R., Buckby J.A., Cosgrave E.M., Killackey E.J., Baker K., Cotton S.M., McGorry P.D. Association between psychotic experiences and depression in a clinical sample over 6months. Schizophr. Res. 2007, 91(1-3):246-253.
61. Yung A.R., McGorry P.D., Francey S.M., Nelson B., Baker K., Phillips L.J., Berger G., Amminger G.P. PACE: a specialised service for young people at risk of psychotic disorders. Med. J. Aust. 2007, 187(7 Suppl.):S43-S46.
62. Yung A.R., Nelson B., Stanford C., Simmons M.B., Cosgrave E.M., Killackey E., Phillips L.J., Bechdolf A., Buckby J., McGorry P.D. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2year follow-up. Schizophr. Res. 2008, 105(1-3):10-17.
63. Zhang T., Chow A., Wang L., Dai Y., Xiao Z. Role of childhood traumatic experience in personality disorders in China. Compr. Psychiatry 2012, 53(6):829-836.
64. Zhang T., Wang L., Good M.J., Good B.J., Chow A., Dai Y., Yu J., Zhang H., Xiao Z. Prevalence of personality disorders using two diagnostic systems in psychiatric outpatients in Shanghai, China: a comparison of uni-axial and multi-axial formulation. Soc. Psychiatry Psychiatr. Epidemiol. 2012, 47(9):1409-1417.
65. Zheng L., Wang J., Zhang T., Li H., Li C., Jiang K. The Chinese version of the SIPS/SOPS: a pilot study of reliability and validity. Chin. Ment. Health J. 2012, 26(8):571-576.